AG
Alexandre Gaymard

Elite Scholar

125
Works
10,419
Citations
33
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Alexandre Gaymard

Also known as: A. Gaymard, Alexandre GAYMARD, Alexandre Gaymard, Gaymard A, Gaymard Alexandre

125

Total Works

10,419

Citations

33

H-Index

52

i10-Index

Citation & Works Trend by Year
14 years active
Top Research Topics
COVID-19 Clinical Research Studies (64) SARS-CoV-2 and COVID-19 Research (59) Respiratory viral infections research (30) Influenza Virus Research Studies (17) COVID-19 epidemiological studies (16)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Fatal encephalitis caused by Shamonda virus Europe 1 (SHAV-EU1) in a patient with a severely weakened immune system, France, 2026 Eurosurveillance 1
2026 Pulmonary Herpes Simplex Virus Reactivation in Invasively Mechanically Ventilated Patients With COVID‐19 in Intensive Care Unit Journal of Medical Virology 0
2026 Emergence of a genetically distinct cluster of influenza A(H3N2) viruses within subclade J.2.2 associated with hospitalization during the 2024–2025 season in Auvergne–Rhône–Alpes, France Microbial Genomics 0
2026 Volatile Organic Compounds (VOCs) as Potential Biomarkers For Legionella pneumophila Infections HAL 0
2026 Complement augments antibody neutralization of SARS-CoV-2 variants Science Translational Medicine 0
2026 Why Andes hantavirus is not the next SARS-CoV-2: contrasting viral shedding, transmissibility and genomic patterns Eurosurveillance 0
2026 Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France The Lancet Microbe 12
2026 High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons The Journal of Infectious Diseases 0
2026 Immune dysregulation through longitudinal lymphocyte trajectories and their clinical determinants in hospitalized COVID-19 patients Intensive Care Medicine Experimental 4
2025 Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in patients hospitalized with COVID-19: long-term results from the DisCoVeRy trial Clinical Microbiology and Infection 1
2025 Urban environment and RSV: a retrospective observational study of neighbourhood factors associated with the risk of severe disease in the infant population of a metropolitan area, Lyon, France BMC Public Health 1
2025 Community and Hospital‐Based Laboratory Surveillance for Influenza, Respiratory Syncytial Virus, and SARS‐CoV‐2 During the 2023–2024 Season, Lyon, France Journal of Medical Virology 2
2025 Rapid-sequence clinical research before and during a pandemic: Lessons learned and the way forward Infectious Diseases Now 0
2025 sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trial Scientific Reports 7
2025 Performance of Subgenomic RT‐PCR for Predicting SARS‐CoV‐2 Infectivity Compared to Genomic RT‐PCR and Culture Isolation Journal of Medical Virology 1

Data source: OpenAlex API